Keck School of Medicine announced $26.5 million grant to fund firstﾠ large-scale study on African-American men with prostate cancer
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
-
-
The Fred & Pamela Buffett Cancer Center opened
On Jun. 5, 2018, a new flagship cancer center was established as the Fred & Pamela Buffett Cancer…
-
Cancer registry managed by Keck School of Medicine of USC received $43.7 million award
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
-
Karmanos Cancer Institute began renovations to expand services in Farmington Hills
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
-
Boykin Family Pledges $10 million to Cleveland Clinic’s Taussig Cancer Institute
On May 18, 2018, the Boykin family pledged $10 million to support Cleveland Clinic’s Taussig Cancer Institute. Paula…
-
UCLA researchers characterized the mechanism of the mammalian EAK-7 gene, or mEAK-7
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
-
The CPRIT awarded academic research and prevention grants totaling $73.5 million
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
-
The University of Michigan Cancer Center was renamed the Rogel Cancer Center
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
-
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
-
Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
-
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
-
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
-
NIH partners with leading companies to accelerate development of cancer immunotherapies
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…
-
Biotechnology | NIH | Oncology | Therapeutics
Emory University selected by National Cancer Institute (NCI) for participation in elite national network for cancer therapeutic discovery
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
-
FDA approval brought first gene therapy to the U.S.
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
-
The CPRIT awarded 60 grants totaling more than $102 million
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
-
NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
-
OHSU Knight Cancer Institute earned National Cancer Institute’s highest distinction
On Jul. 10, 2017, the OHSU Knight Cancer Institute was awarded the National Cancer Institute’s premier status: Comprehensive…
-
Canadian researchers reconstituted an extinct poxvirus using mail-order DNA
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
-
Winship awarded NCI-designated comprehensive cancer center status
On May 15, 2017, Winship Cancer Institute of Emory University earned the prestigious comprehensive cancer center designation from…
-
Siteman Cancer Center met the standards of the American Society for Radiation Oncology Accreditation Program for Excellence
On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…
-
The University of Virginia Cancer Center received $15 million Renewal grant
On Apr. 26, 2017, the University of Virginia Cancer Center was honored as one of just 69 National…
-
Bezos family donated $35 million to Fred Hutch
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
-
Cleveland Clinic opened new cancer Center
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
-
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
-
BioXcel therapeutics was founded
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
-
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
-
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
-
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
-
Biotechnology | Chemistry | Disease | FDA | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
